Literature DB >> 17308979

Liver-derived cell lines QSG-7701 and HepG2 support different HBV replication patterns.

X B Pan1, L Wei, H S Chen, F Liu, Y Gao.   

Abstract

Hepatitis B virus (HBV) infection is currently still a worldwide heath concern. In our study, we compared HBV replication patterns in two liver-derived cell lines, QSG-7701 and HepG2. Viral markers of HBV replication in culture medium and cells were analyzed after transfection of these cells with plasmid pUC18-HBV1.2 into. We showed that QSG-7701 cells could support more stable and a higher level of HBV replication than HepG2 cells. Gene expression profiles of QSG-7701 and HepG2 cells by microarray analysis showed that many genes were differentially expressed between these two cell lines, including those that are related to the HBV life cycle. The global gene expression profile of these two cell types provides some clues to explain how different HBV replication is achieved. QSG-7701 cells offer a new opportunity for basic research on HBV virus-host interactions.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17308979     DOI: 10.1007/s00705-006-0927-4

Source DB:  PubMed          Journal:  Arch Virol        ISSN: 0304-8608            Impact factor:   2.574


  3 in total

1.  Effects of hepatitis B virus mutations on its replication and liver disease severity.

Authors:  Abdulrahim Hakami; Abdelwahid Ali; Ahmed Hakami
Journal:  Open Virol J       Date:  2013-01-23

2.  2',3'-cyclic nucleotide 3'-phosphodiesterases inhibit hepatitis B virus replication.

Authors:  Hui Ma; Xing-Liang Zhao; Xue-Yan Wang; Xing-Wang Xie; Jin-Chao Han; Wen-Li Guan; Qin Wang; Lin Zhu; Xiao-Ben Pan; Lai Wei
Journal:  PLoS One       Date:  2013-11-18       Impact factor: 3.240

3.  The enhanced expression of death receptor 5 (DR5) mediated by HBV X protein through NF-kappaB pathway is associated with cell apoptosis induced by (TNF-α related apoptosis inducing ligand) TRAIL in hepatoma cells.

Authors:  Fanyun Kong; Hongjuan You; Jinjin Zhao; Wen Liu; Lei Hu; Wenya Luo; Wei Hu; Renxian Tang; Kuiyang Zheng
Journal:  Virol J       Date:  2015-11-17       Impact factor: 4.099

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.